REVERSE CONVERTIBLE - PFIZER INC/PHILIP MORRIS/ALTRIA GROUP Stock

Certificat

RMAZ2V

CH1283324742

Delayed Swiss Exchange 22:05:50 2023-09-07 EDT
100 USD -.--% Intraday chart for REVERSE CONVERTIBLE - PFIZER INC/PHILIP MORRIS/ALTRIA GROUP

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Vontobel Vontobel
RMAZ2V
ISINCH1283324742
Date issued 2023-08-31
Strike 30.56 $
Maturity 2026-03-02 (659 Days)
Parity 0.03 : 1
Emission price 100 $
Emission volume N/A
Settlement both
Currency USD

Technical Indicators

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.01 USD
Average target price
31.94 USD
Spread / Average Target
+14.02%
Consensus
  1. Stock Market
  2. Certificates
  3. RMAZ2V Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW